top of page
All Posts


The Quiet Advantage: Why Speaking Less in Meetings Is a Powerful Skill in Pharma
In many pharmaceutical companies, meetings are everywhere. There are project updates, cross-functional discussions, alignment calls, and decision boards. It often feels like a big part of the job is simply attending and talking in meetings. In this environment, there is a quiet skill that is rarely talked about but incredibly valuable: knowing when not to speak. At first, silence can be misunderstood. People may think that if you are quiet, you are not engaged, not prepared,
-
1 day ago3 min read


What is Regulatory Affairs Leadership? Beyond Checklists, Deadlines, and “Because I Say So”
In industries like pharmaceuticals, medical devices, and biotech, regulatory affairs is often described as the function that “gets products approved” or “keeps companies compliant.” That’s true, but incomplete. When people talk about regulatory affairs leadership , the conversation too often drifts toward authority: who signs off, who enforces procedures, who pushes submissions out the door on time. Let’s be clear: ordering people around, escalating everything, and hiding be
-
Mar 263 min read


Why RA, QA, Supply Chain, and Commercial Need to Actually Talk to Each Other
Have you ever felt like Regulatory Affairs (RA), Quality Assurance (QA), Supply Chain, and Commercial are all working for the same company… but on completely different planets? RA is busy making sure every “i” is dotted and every rule is followed. QA is obsessively checking that nothing goes wrong. Supply Chain is chasing delivery deadlines like an Olympic athlete. And Commercial… well, they just want the product on the market yesterday. Then deadlines slip, approvals are del
-
Mar 53 min read


The Skill Regulatory Affairs Must Strengthen First: How We Communicate with Senior Leadership
In Regulatory Affairs, we are highly trained professionals. We understand guidelines, scientific data, risk assessments, and submission strategies. We are precise. We are careful. We are thorough. But there is one area where our profession still needs significant improvement: how we communicate with senior leadership. Before Regulatory Affairs can increase its strategic influence, it must first ensure that it is clearly understood. And too often, this is where the gap appears
-
Feb 152 min read


What to expect from the pharmaceutical industry this year? Honest answer, nobody knows
Every year, around this time, the pharmaceutical industry turns into a room full of oracles. LinkedIn feeds, conference panels, whitepapers, keynote speeches, everyone seems ready to tell you exactly what will happen next. Which technologies will win. Which markets will explode. Which strategies are “the only way forward.” The funny part? None of us actually knows. And that’s not false modesty. It’s just reality. The pharma industry is influenced by an almost absurd number
-
Feb 83 min read


Why Pharma Hiring Is Slowing Down: A Transparent Look at What’s Really Happening Behind the Scenes
If you’ve been job searching or hiring in the pharmaceutical and biotech industry lately, you’ve probably felt it: The market is unusually slow. Fewer openings, longer hiring cycles, more competition, and companies taking weeks (sometimes months) to make decisions they used to make much faster. The slowdown isn’t imaginary and it isn’t driven by one single factor. It’s the result of several forces all hitting the industry at the same time. Some are global. Some are organizati
-
Nov 15, 20254 min read


🎻 The Evolution of Regulatory Affairs: From Submissions to Strategic Orchestrators
Not so long ago, working in Regulatory Affairs meant one thing: preparing submissions, tracking approvals, and making sure everything stayed compliant. It was an essential job, but often seen as a “back-office” function, a technical role that ensured the product got to market safely. Fast forward to today, and that definition no longer fits. Regulatory Affairs has evolved into something much broader, much more connected, and let’s be honest, much more complex. The modern Regu
-
Nov 9, 20254 min read


🚨 The Real Reason Pharma Is Struggling To Keep The Market Pace: Too Many Voices. Not Enough Deciders.
We talk a lot in pharma about challenges — tough regulations, rising R&D costs, and long timelines. But let’s be honest: The biggest...
-
Aug 28, 20252 min read


Big Pharma vs. Small Pharma/biotech
Here’s a more personalized comparison between Big Pharma and Small Pharma/biotech , pitched as if we’re sharing a coffee — your career...
-
Jul 26, 20253 min read


💊 Medicine Prices: Why Higher Prices Might Actually Save More Lives (and Money)
When we hear about rising medicine prices, the instinctive reaction is concern, and for good reason. Millions of people struggle to...
-
May 3, 20253 min read


The Art of Predicting Procedure Timelines with Accuracy in Regulatory Affairs
Accurate prediction of procedure timelines is one of the most significant challenges in regulatory affairs. A product approval process (a...
-
Apr 5, 20253 min read


The Regulatory Affairs Department: Key to Modern Business Success
In today's global business landscape of intense regulation and speed, the Regulatory Affairs (RA) department has become an essential...
-
Mar 22, 20254 min read


How Regulatory Affairs Can Communicate Effectively with Upper Management in Pharmaceutical Companies
How Regulatory Affairs Can Communicate Effectively with Upper Management in Pharmaceutical Companies In the pharmaceutical industry,...
-
Mar 9, 20254 min read
bottom of page